MA41623A - Composition lyophilisée de composé de benzimidazole - Google Patents

Composition lyophilisée de composé de benzimidazole

Info

Publication number
MA41623A
MA41623A MA041623A MA41623A MA41623A MA 41623 A MA41623 A MA 41623A MA 041623 A MA041623 A MA 041623A MA 41623 A MA41623 A MA 41623A MA 41623 A MA41623 A MA 41623A
Authority
MA
Morocco
Prior art keywords
lyophilized composition
benzimidazole compound
benzimidazole
compound
lyophilized
Prior art date
Application number
MA041623A
Other languages
English (en)
Inventor
Ali Türkyilmaz
Gülay Yelken
Original Assignee
Verano Ilac Sanayi Ve Ticaret A S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Verano Ilac Sanayi Ve Ticaret A S filed Critical Verano Ilac Sanayi Ve Ticaret A S
Publication of MA41623A publication Critical patent/MA41623A/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MA041623A 2015-11-26 2016-11-24 Composition lyophilisée de composé de benzimidazole MA41623A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR201515019 2015-11-26

Publications (1)

Publication Number Publication Date
MA41623A true MA41623A (fr) 2018-01-09

Family

ID=57421667

Family Applications (1)

Application Number Title Priority Date Filing Date
MA041623A MA41623A (fr) 2015-11-26 2016-11-24 Composition lyophilisée de composé de benzimidazole

Country Status (3)

Country Link
EP (1) EP3173070A1 (fr)
MA (1) MA41623A (fr)
WO (1) WO2017089512A1 (fr)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3915986A (en) 1974-06-19 1975-10-28 Smithkline Corp Methyl 5-propylthio-2-benzimidazolecarbamate
US4076828A (en) 1977-02-17 1978-02-28 E. R. Squibb & Sons, Inc. Method of treating helminthiasis by parenteral administration of sulfoxide derivatives of benzimidazoles
CA2163455A1 (fr) 1993-05-26 1994-12-08 Desmond Ronald Hennessy Compositions antiparasitaires
EP1713476B1 (fr) * 2003-11-05 2010-05-05 Lyka Labs Limited Procede pour la preparation de benzimidazoles
US8158152B2 (en) * 2005-11-18 2012-04-17 Scidose Llc Lyophilization process and products obtained thereby

Also Published As

Publication number Publication date
EP3173070A1 (fr) 2017-05-31
WO2017089512A1 (fr) 2017-06-01

Similar Documents

Publication Publication Date Title
DK3436444T3 (da) Heterocyklisk forbindelse
DK3360864T3 (da) Pyrimidinforbindelse
MA45940A (fr) Composé hétérocyclique
DK3298027T3 (da) Anthelmintiske depsipeptidforbindelser
DK3250182T3 (da) Dispergible sammensætninger
FI20150334A (fi) Paranneltu puolijohdekokoonpano
DK3334726T3 (da) Plinabulinsammensætninger
DK3370949T3 (da) Sammensætning af tætningsmiddel
KR20180084853A (ko) 지혈 조성물
DK3283210T3 (da) Fremgangsmåde
BR112016030730A2 (pt) Composto
DK3597189T3 (da) Krystallinske forbindelser
MA43275A (fr) Composé de pyranodipyridine
DK3331498T3 (da) Nasalsammensætning
BR112018001062A2 (pt) compostos inovadores
DK3347403T3 (da) Polyalkoxyfedtforbindelse
DK3316857T3 (da) Multifasiske sammensætninger
DE102015105763A8 (de) Korrosionsschutzzusammensetzung
DK3393254T3 (da) Sammensætning
DK3416502T3 (da) Glykæmisk-reducerende sammensætning
FI20160183L (fi) Parannettu puolijohdekokoonpano
BR112018000396A2 (pt) composições de nicergolina de liberação modificada
DK3528791T3 (da) Dispergible sammensætninger
DK3337322T3 (da) Fungicidsammensætninger
DK3322295T3 (da) Sammensætning